Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vycor Medical (VYCO) Operating Income (2016 - 2025)

Vycor Medical has reported Operating Income over the past 16 years, most recently at -$36525.0 for Q4 2025.

  • Quarterly Operating Income fell 705.82% to -$36525.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33900.0 through Dec 2025, up 250.93% year-over-year, with the annual reading at $33900.0 for FY2025, 250.93% up from the prior year.
  • Operating Income was -$36525.0 for Q4 2025 at Vycor Medical, down from $32085.0 in the prior quarter.
  • Over five years, Operating Income peaked at $96520.0 in Q2 2023 and troughed at -$206849.0 in Q1 2021.
  • The 5-year median for Operating Income is -$30308.0 (2023), against an average of -$34541.8.
  • Year-over-year, Operating Income soared 229.78% in 2023 and then crashed 705.82% in 2025.
  • A 5-year view of Operating Income shows it stood at -$164198.0 in 2021, then soared by 44.46% to -$91196.0 in 2022, then rose by 29.76% to -$64056.0 in 2023, then skyrocketed by 109.41% to $6029.0 in 2024, then crashed by 705.82% to -$36525.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Operating Income are -$36525.0 (Q4 2025), $32085.0 (Q3 2025), and $51146.0 (Q2 2025).